As leukemia options grow, drugs jockey to be first-line therapies

被引：1
|
作者：
Dolgin, Elie
机构：
来源：
NATURE MEDICINE | 2013年 / 19卷 / 01期
关键词：
CHRONIC MYELOID-LEUKEMIA; IMATINIB;
D O I：
10.1038/nm0113-7
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [31] Helicobacter pylori therapy:: First-line options and rescue regimen
    Gisbert, JP
    Pajares, JM
    DIGESTIVE DISEASES, 2001, 19 (02) : 134 - 143
  • [32] What are the treatment options for myasthenia gravis if first-line fail?
    Zust, Christopher
    Morren, John A.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2023, 90 (02) : 81 - 84
  • [33] Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
    Meloni, Seema T.
    Onwuamah, Chika K.
    Agbaji, Oche
    Chaplin, Beth
    Olaleye, David O.
    Audu, Rosemary
    Samuels, Jay
    Ezechi, Oliver
    Imade, Godwin
    Musa, Adesola Z.
    Odaibo, Georgina
    Okpokwu, Jonathan
    Rawizza, Holly
    Mu'azu, Muhammad A.
    Dalhatu, Ibrahim
    Ahmed, Mukhtar
    Okonkwo, Prosper
    Raizes, Elliot
    Ujah, Innocent A. O.
    Yang, Chunfu
    Idigbe, Emmanuel O.
    Kanki, Phyllis J.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (04):
  • [34] Expanding first-line therapy options for children with partial seizures
    Glauser, TA
    NEUROLOGY, 2000, 55 (11) : S30 - S37
  • [35] The impact of first-line antihypertensive drugs on erectile dysfunction
    Barksdale, JD
    Gardner, SF
    PHARMACOTHERAPY, 1999, 19 (05): : 573 - 581
  • [36] AEs of first-line drugs for patent ductus arteriosis
    Reactions Weekly, 2024, 2030 (1) : 5 - 5
  • [37] Use of Clays as Nanocarriers of First-Line Tuberculostatic Drugs
    Carazo, Esperanza
    Borrego-Sanchez, Ana
    Aguzzi, Carola
    Cerezo, Pilar
    Viseras, Cesar
    CURRENT DRUG DELIVERY, 2017, 14 (07) : 902 - 903
  • [38] Pharmacokinetics of First-Line Anti-Tubercular Drugs
    Mukherjee, Aparna
    Lodha, Rakesh
    Kabra, S. K.
    INDIAN JOURNAL OF PEDIATRICS, 2019, 86 (05): : 468 - 478
  • [39] Benefits of using multiple first-line therapies against malaria
    Boni, Maciej F.
    Smith, David L.
    Laxminarayan, Ramanan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (37) : 14216 - 14227
  • [40] Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients
    Tostmann, Alma
    Mtabho, Charles M.
    Semvua, Hadija H.
    van den Boogaard, Jossy
    Kibiki, Gibson S.
    Boeree, Martin J.
    Aarnoutse, Rob E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 3208 - 3213
12345